Background. Rapid identification of Gram positive (GP) bacteria from blood cultures can help narrow antimicrobial therapy toward the offending pathogen or discontinue unnecessary antibiotics for contaminants. The Verigene 1 GP blood culture assay is a nucleic acid test that identifies 10 organisms and select resistance genes in 2.5 hours from positive blood cultures. This study evaluates the use of the Verigene 1 assay, or optimized standard identification of blood GP isolates, in combination with real-time support from the Antibiotic Stewardship Team (AST) in a community hospital system.
Methods. This multi-center, pre-post quasi-experimental study was conducted at the five hospitals that compose Scripps Healthcare. Rapid diagnostic testing was performed at a central laboratory from 7am-7pm. If cultures became positive overnight, routine identification was done first thing in the morning. Pharmacists notified physicians of results and assisted with antibiotic modifications. The primary outcomes were average time to optimal antibiotic therapy and difference in antibiotic duration for contaminants. Secondary endpoints included hospital length of stay, mortality, pharmacy and overall hospitalization costs. Adult patients with a GP bacteremia admitted in 2011 ( pre-rapid testing) were compared to those admitted in 2014 ( postrapid testing).
Results. There were 110 patients in the preintervention group and 65 patients in the intervention group. The optimized GP identification process, combined with AST intervention improved time to optimal antibiotic therapy (60.6 vs 35.3 hours, p < 0.0001). Duration of antibiotic therapy for blood cultures considered to be a contaminant decreased in the intervention group (44.2 vs 24.5 hours, p = 0.0171). Length of stay (14.1 vs 9.0 days, p = 0.0162), pharmacy costs ($1,957 vs $1,115, p = 0.16), and overall hospitalization costs ($27,245 vs $16,698, p = 0.02) were lower in the intervention group. Mortality was similar between groups (9.1% vs 9.2%, p = 0.55).
Conclusion. Rapid identification of GP blood cultures with AST intervention decreased time to optimal antibiotic therapy, length of unnecessary antibiotic therapy for blood culture contaminants, length of stay, and overall hospital and pharmacy costs.
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